Back
Novo Nordisk A/S Vs. Evaxion Biotech AS Industry Stock Comparison
Buy
66
NVO
Novo Nordisk A/S
Last Price:
129.29
Seasonality Move:
4.82%
Sell
21
EVAX
Evaxion Biotech AS
Last Price:
3.71
Seasonality Move:
-4.73%
Buy
66
Novo Nordisk A/S (NVO)
is a Buy
Is Novo Nordisk A/S a Buy, Sell or Hold?
- The current Novo Nordisk A/S [NVO] share price is $128.66. The Score for NVO is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
- NVO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
21
Evaxion Biotech AS (EVAX)
is a Sell
Is Evaxion Biotech AS a Buy, Sell or Hold?
- The current Evaxion Biotech AS [EVAX] share price is $3.77. The Score for EVAX is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
- EVAX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NVO Stock Price Chart
What is Novo Nordisk A/S's stock price today?
-
The Novo Nordisk A/S share price today is $128.66
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVO is experiencing buying pressure, which is a positive indicator for future bullish movement.
EVAX Stock Price Chart
What is Evaxion Biotech AS's stock price today?
-
The Evaxion Biotech AS share price today is $3.77
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EVAX is experiencing slight buying pressure.
NVO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.2 | Buy |
| Relative Strength Index (14 RSI): | 56.04 | Buy |
| Chaikin Money Flow: | 2009806 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (123.8 - 127.54) | Buy |
| Bollinger Bands (100): | (108.95 - 129.55) | Buy |
EVAX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.02 | Buy |
| Relative Strength Index (14 RSI): | 43.47 | Sell |
| Chaikin Money Flow: | -29 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.82 - 4.2) | Sell |
| Bollinger Bands (100): | (3.02 - 6.48) | Sell |
NVO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 126.48 | Buy |
| 20-day SMA: | 125.66 | Buy |
| 50-day SMA: | 127.44 | Buy |
| 200-day SMA: | 107.06 | Buy |
| 8-day EMA: | 126.62 | Buy |
| 20-day EMA: | 126.27 | Buy |
| 50-day EMA: | 124.87 | Buy |
| 200-day EMA: | 109.04 | Buy |
EVAX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.92 | Sell |
| 20-day SMA: | 4.06 | Sell |
| 50-day SMA: | 3.59 | Buy |
| 200-day SMA: | 6.72 | Sell |
| 8-day EMA: | 3.91 | Sell |
| 20-day EMA: | 3.93 | Sell |
| 50-day EMA: | 4.03 | Sell |
| 200-day EMA: | 7.08 | Sell |
Novo Nordisk A/S Earnings Growth & NVO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.85 per share, and an increase next year of $0.66 per share.
Evaxion Biotech AS Earnings Growth & EVAX Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.86 per share, and an increase next year of $1.97 per share.
Novo Nordisk A/S Technical Analysis
| Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Evaxion Biotech AS Technical Analysis
| Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||